BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 8676570)

  • 21. Mutation and expression analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in pituitary tumors.
    Takeuchi S; Koeffler HP; Hinton DR; Miyoshi I; Melmed S; Shimon I
    J Endocrinol; 1998 May; 157(2):337-41. PubMed ID: 9659297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the human p27(Kip1) promoter by IFNalpha 2b.
    Moro A; Santos A; AraƱa MJ; Perea SE
    Biochem Biophys Res Commun; 2000 Mar; 269(1):31-4. PubMed ID: 10694472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of the polymerase chain reaction to the ribonuclease protection assay.
    Yang H; Melera PW
    Biotechniques; 1992 Dec; 13(6):922-7. PubMed ID: 1476748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Streptogramin- and tetracycline-responsive dual regulated expression of p27(Kip1) sense and antisense enables positive and negative growth control of Chinese hamster ovary cells.
    Fux C; Moser S; Schlatter S; Rimann M; Bailey JE; Fussenegger M
    Nucleic Acids Res; 2001 Feb; 29(4):E19. PubMed ID: 11160939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutational analysis of the p27(kip1) gene in hepatocellular carcinoma.
    Chen TC; Ng KF; Lien JM; Jeng LB; Chen MF; Hsieh LL
    Cancer Lett; 2000 May; 153(1-2):169-73. PubMed ID: 10779646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced ribosomal association of p27(Kip1) mRNA is a mechanism contributing to accumulation during growth arrest.
    Millard SS; Yan JS; Nguyen H; Pagano M; Kiyokawa H; Koff A
    J Biol Chem; 1997 Mar; 272(11):7093-8. PubMed ID: 9054402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sp1 and NF-Y synergistically mediate the effect of vitamin D(3) in the p27(Kip1) gene promoter that lacks vitamin D response elements.
    Inoue T; Kamiyama J; Sakai T
    J Biol Chem; 1999 Nov; 274(45):32309-17. PubMed ID: 10542271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A cytosine analog that confers enhanced potency to antisense oligonucleotides.
    Flanagan WM; Wolf JJ; Olson P; Grant D; Lin KY; Wagner RW; Matteucci MD
    Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3513-8. PubMed ID: 10097067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of cyclin messenger RNAs by nonradioactive ribonuclease protection assay: a comparison of four detection methods.
    Nass SJ; Dickson RB
    Biotechniques; 1995 Nov; 19(5):772-6, 778. PubMed ID: 8588915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The murine gene Cdkn1b (p27(Kip1)) maps to distal chromosome 6 and is excluded as Pas1.
    Kemp CJ; Kim KH; Philipp J
    Mamm Genome; 2000 May; 11(5):402-4. PubMed ID: 10790542
    [No Abstract]   [Full Text] [Related]  

  • 31. Multiprobe RNase protection assay with internally labeled radioactive probes, generated by RT-PCR and nested PCR.
    von Wolff M; Tabibzadeh S
    Front Biosci; 1999 Jul; 4():C1-3. PubMed ID: 10393129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNA purification and quantification methods.
    Jones A; Fujiyama C; Smith K
    Methods Mol Med; 2001; 57():241-53. PubMed ID: 21340902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chimeric probe-mediated ribonuclease protection assay for molecular diagnosis of mRNA deficiencies.
    Maillet P; Delaunay J; Baklouti F
    Hum Mutat; 1996; 7(1):61-4. PubMed ID: 8664903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Detection of p27/kip1 mRNA in blood cells by nonradioactive ribonuclease protection assay].
    Okamoto Y; Nakabayashi H; Kikukawa S; Nakano H
    Rinsho Byori; 1996 May; 44(5):483-6. PubMed ID: 8676570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies.
    Kawamata N; Morosetti R; Miller CW; Park D; Spirin KS; Nakamaki T; Takeuchi S; Hatta Y; Simpson J; Wilcyznski S
    Cancer Res; 1995 Jun; 55(11):2266-9. PubMed ID: 7757974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p27/Kip1 mutation found in breast cancer.
    Spirin KS; Simpson JF; Takeuchi S; Kawamata N; Miller CW; Koeffler HP
    Cancer Res; 1996 May; 56(10):2400-4. PubMed ID: 8625318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours.
    Dahia PL; Aguiar RC; Honegger J; Fahlbush R; Jordan S; Lowe DG; Lu X; Clayton RN; Besser GM; Grossman AB
    Oncogene; 1998 Jan; 16(1):69-76. PubMed ID: 9467944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple functions of p27(Kip1) and its alterations in tumor cells: a review.
    Sgambato A; Cittadini A; Faraglia B; Weinstein IB
    J Cell Physiol; 2000 Apr; 183(1):18-27. PubMed ID: 10699962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ribonuclease protection assay: a powerful tool for the veterinary pathologist.
    Rottman JB
    Vet Pathol; 2002 Jan; 39(1):2-9. PubMed ID: 12102215
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.